spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  angina 

 HSMN NewsFeed - 20 Sep 2019
CHMP Issues Positive Opinion to Expand Trulicity(R) (dulaglutide) Label to Include Results from REWIND Cardiovascular Outcomes Trial
Biopharmaceuticals Endocrinology Cardiology Regulatory
 HSMN NewsFeed - 10 Sep 2019
Milestone Pharmaceuticals Announces Appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 12 Jul 2019
Neovasc to Explore HDE Approval Pathway and Alternate Trial Designs for the Reducer Following Guidance from the FDA
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Mar 2019
Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship of a European Patent for Tiara(TM)
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 20 Feb 2019
Neovasc Provides Corporate Update
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 Feb 2019
Pierangeli Clinic Initiates Program Providing Neovasc Reducer(TM) Procedure to Italian Patients with Refractory Angina
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Feb 2019
CHMP Recommends Approval of Praluent(R) (alirocumab) Injection to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 22 Jan 2019
Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 Dec 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Oct 2018
Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer(TM)
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Oct 2018
FDA Approves KYPROLIS(R) (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone (Kd70) For Patients With Relapsed Or Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Sep 2018
FDA to Review Supplemental Biologics License Application for Praluent(R) (alirocumab)Injection as Potential Treatment to Reduce Major Adverse Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 28 Aug 2018
European Society of Cardiology incorporates iFR technology into updated guidelines for revascularization
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Jul 2018
MEDICALgorithmics, Medi-Lynx Receive FDA 510(K) Clearance for PocketECG CRS Mobile Cardiac Rehabilitation System
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 20 Jun 2018
Neovasc Announces First Implant of a Neovasc Reducer(TM) in a U.S. Patient
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Jun 2018
Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update
Devices Cardiology Personnel
 HSMN NewsFeed - 25 May 2018
Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Mar 2018
Amgen Receives Positive CHMP Opinion Recognizing That Repatha(R) (evolocumab) Prevents Heart Attacks And Strokes
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 12 Feb 2018
Ferring's CLENPIQ(TM) (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep Now Available
Biopharmaceuticals Gastroenterology Product Launch
 HSMN NewsFeed - 1 Feb 2018
Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer(TM) Procedure for Treatment of Refractory Angina
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 22 Jan 2018
Fred Colen Appointed Chief Executive Officer of Neovasc Inc.
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 12 Dec 2017
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 20 Nov 2017
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
Biopharmaceuticals FDA Licensing
 HSMN NewsFeed - 13 Nov 2017
PlaqueTec Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as Chief Executive Officer
Devices Diagnostics Cardiology Personnel
 HSMN NewsFeed - 6 Nov 2017
Neovasc Receives FDA Approval to Initiate Pivotal Reducer Trial
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 12 Sep 2017
Neovasc Provides Tiara(TM) Clinical Update
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Sep 2017
Neovasc's Reducer System Reviewed in European Heart Journal
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Jul 2017
FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For Repatha(R) (evolocumab) To Include Data On Reducing Risk Of Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 16 May 2017
Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Mar 2017
Landmark Outcomes Study Shows that Repatha(R) (evolocumab) Decreases LDL-C to Unprecedented Low Levels and Reduces Risk of Cardiovascular Events with No New Safety Issues
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Feb 2017
Amgen Announces Repatha(R) (Evolocumab) Significantly Reduced The Risk Of Cardiovascular Events In FOURIER Outcomes Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Dec 2016
Boston Scientific Closes Acquisition of Advanced Biological Tissue Capabilities and Acquires Common Shares of Neovasc, Inc.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 6 Dec 2016
Neovasc Provides Update on its Tiara(TM) Mitral Valve Clinical Program
Devices Cardiology Surgery
 HSMN NewsFeed - 2 Dec 2016
Boston Scientific Announces Agreement to Acquire Neovasc Advanced Biological Tissue Capabilities
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 17 Nov 2016
Regeneron and Sanofi Announce Praluent(R) (alirocumab) Cardiovascular Outcomes Trial Will Continue as Planned Following Interim Analysis
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2016
Neovasc Announces Update in Litigation with CardiAQ
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 29 Aug 2016
New Repatha(R) (evolocumab) Analyses Show Efficacy and Safety Across Risk Groups in Results Presented at ESC Congress 2016
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 4 Jul 2016
European Commission Approves Extended Indication For Amgen's Kyprolis(R) (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 6 Jun 2016
Allergan Announces FDA Approval of BYVALSON(TM) (nebivolol and valsartan)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 4 Apr 2016
ANI Pharmaceuticals Closes Acquisition of Inderal(R) LA Assets
Biopharmaceuticals Cardiology Acquisitions
 HSMN NewsFeed - 16 Sep 2015
Espero Pharmaceuticals Announces Exclusive Licensing and Distribution Agreement
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 24 Jul 2015
Regeneron and Sanofi Announce FDA Approval of Praluent(R) (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 12 Mar 2015
CryoLife Provides Update on PerClot Litigation
Devices Surgery Litigation
 HSMN NewsFeed - 18 Dec 2014
The Medicines Company and SciClone Pharmaceuticals Establish Strategic Partnership for Two Cardiovascular Products in China
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 9 Oct 2014
Neovasc Receives FDA Conditional Approval to Initiate TIARA-I Trial in US: A Multinational, Multicenter Early Feasibility Trial of the Tiara(TM) Transcatheter Mitral Valve
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 10 Jul 2014
CryoLife Appoints Pat Mackin as President and Chief Executive Officer
Devices Surgery Personnel
 HSMN NewsFeed - 8 May 2014
Neovasc Hires Industry Veteran Vicki Bebeau as Vice President, Clinical Affairs
Devices Cardiology Personnel
 HSMN NewsFeed - 29 Apr 2014
CryoLife Receives FDA 510(k) Clearance for PerClot(R) Topical Hemostatic Powder in the U.S.
Devices FDA
 HSMN NewsFeed - 24 Apr 2014
Endo Acquires Rights to Sumavel(R) DosePro(R)
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 27 Mar 2014
CryoLife Acquires Distribution Rights and Purchase Option for ProCol(R) Vascular Bioprosthesis for Hemodialysis Access
Devices Distribution
 HSMN NewsFeed - 3 Feb 2014
Neovasc Inc. Announces Successful First Human Implant of Tiara(TM) Transcatheter Mitral Valve
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Jan 2014
FDA Reclassifies ECP Devices for Refractory Angina as Class II
Devices Cardiology FDA
 HSMN NewsFeed - 2 Dec 2013
InspireMD Appoints Rick Olson as Vice President of Global Sales Operations
Devices Interventional Personnel
 HSMN NewsFeed - 6 Nov 2013
Neovasc Reducer(TM) Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Functional Capabilities in Patients with Refractory Angina
Devices Cardiology
 HSMN NewsFeed - 30 Oct 2013
The Medicines Company's EUROMAX Trial of Angiox(R) (Bivalirudin) in Heart Attack Meets All Prespecified Endpoints
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 9 Oct 2013
First Patient Enrolled in Phase III Trial Evaluating The Medicines Company's Angiomax(R) (Bivalirudin) in Patients Undergoing Peripheral Endovascular Procedures
Biopharmaceuticals Interventional
 HSMN NewsFeed - 4 Sep 2013
InspireMD Announces New Appointment to the Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 31 Jul 2013
New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on Findings of Reduced Rate of Stent Thrombosis With BRILINTA (ticagrelor)
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jul 2013
Boston Scientific Launches Guidezilla(TM) Guide Extension Catheter in U.S. and Europe
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 10 Jul 2013
CryoLife Receives FDA Premarket Approval (PMA) for New Sologrip Minimally Invasive TMR Laser Fiber-Optic Delivery System
Devices Cardiology FDA
 HSMN NewsFeed - 9 Jul 2013
CryoLife Enhances International Presence with Appointment of Andres Sarmiento as Latin America Sales Manager
Devices Surgery Cardiology Personnel
 HSMN NewsFeed - 23 May 2013
InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2013
Registry Data Presented at EuroPCR 2013 Confirms the Neovasc Reducer(TM) Improves Cardiovascular Parameters in Refractory Angina Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2013
InspireMD Announces Reimbursement Coverage for MGuard(TM) Coronary Embolic Protection Stent
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 8 Apr 2013
NovaDel Announces the Signing of a Definitive Agreement to Sell its NovaMist(TM) Technology and Certain Other Assets
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 4 Apr 2013
CryoLife Receives FDA Clearance For Next Generation HeRO Device
Devices FDA
 HSMN NewsFeed - 5 Feb 2013
ZALTRAP(R) (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Dec 2012
Lilly Provides Update on Next Steps for Solanezumab
Biopharmaceuticals Neurology
 HSMN NewsFeed - 4 Dec 2012
Clinical study results using Miracor’s PICSO(R) system show potential to treat severe heart attack (STEMI) patients and are published in December’s Journal of Interventional Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Nov 2012
ZYTIGA(R) Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Nov 2012
Neovasc Inc. Finalizes US $4.6 Million Agreement Giving Lemaitre Vascular Rights to In-House Manufacture of Xenosure(R) Surgical Patch
Devices Surgery Licensing
 HSMN NewsFeed - 11 Oct 2012
First Patient Treated in Cytori’s U.S. Cell Therapy Heart Failure Trial
Regenerative Medicine Cardiology
 HSMN NewsFeed - 27 Sep 2012
Boston Scientific Launches Emerge(TM) PTCA Balloon Dilatation Catheter in the U.S.
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 24 Sep 2012
Ventrus Biosciences Appoints JP Benya Vice President, Commercial Operations and Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2012
Cialis(R) (tadalafil) Tablets Recommended for Approval for the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia in the European Union
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 24 Aug 2012
Eli Lilly and Company Announces Top-Line Results on Solanezumab Phase 3 Clinical Trials in Patients with Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Jul 2012
CardioDx’s Corus CAD Gene Expression Test Performs Equally Well in Both Women and Men for the Assessment of Obstructive Coronary Artery Disease, Study Shows
Diagnostics Cardiology
 HSMN NewsFeed - 20 Jul 2012
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis(TM) (carfilzomib) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 May 2012
CryoLife to Acquire Hemosphere
Devices Mergers & Acquisitions
 HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2012
Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition
Regenerative Medicine Cardiology
 HSMN NewsFeed - 28 Feb 2012
Miracor receives $3.5 million cash infusion to begin pivotal clinical “RAMSES” trial of its PICSO system, designed to improve myocardial perfusion following primary PCI
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Feb 2012
Miraculins Appoints Distinguished U.S. Cardiologist Dr. Henry Solomon to PreVu Medical Advisory Board
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 7 Feb 2012
New Study Evaluates Cialis(R) in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 20 Jan 2012
NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 3 Jan 2012
Novadaq Names MAQUET Cardiovascular Exclusive U.S. Distributor of CO2 Heart Laser Products
Devices Cardiology Distribution
 HSMN NewsFeed - 4 Nov 2011
Miracor to Report Successful Clinical Study Results of Its PICSO(R) System Designed to Improve Myocardial Perfusion Following Primary PCI
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2011
Vasomedical Announces Corporate Restructure and Appointment of New Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 23 Aug 2011
Vasomedical Announces Agreement to Acquire Two China-based Companies
Devices Mergers & Acquisitions
 HSMN NewsFeed - 17 Aug 2011
OPKO Invests in Cardiac Device Company
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Jul 2011
Vasomedical Receives FDA 510(k) Clearance on Two Additional BIOX(TM) Monitors
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 29 Jun 2011
Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent(R) Drug-Eluting Coronary Stent Based on Early Clinical Data
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Jun 2011
NovaDel Announces Changes in Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2011
Accumetrics Signs National Distribution Agreement with Cardinal Health
Diagnostics Personalized Medicine Cardiology Distribution
 HSMN NewsFeed - 31 Mar 2011
VICTRELIS(TM) (boceprevir), Merck's Investigational Medicine, Added to Peginterferon Alfa-2a and Ribavirin Achieved Significantly Higher SVR Rates In Treatment-Failure Patients with Chronic HCV Genotype 1 Compared to Control
Biopharmaceuticals
 HSMN NewsFeed - 22 Mar 2011
Data Presented at AAAAI Annual Meeting Further Support the Safety and Efficacy of FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema
Biopharmaceuticals
 HSMN NewsFeed - 2 Mar 2011
Vasomedical Positioned to Seek Increased Reimbursement Coverage for EECP(R) Therapy
Devices Cardiology Reimbursement Personnel
 HSMN NewsFeed - 28 Feb 2011
Shire Files Complete Response to FDA's Not Approvable Letter for FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Feb 2011
Neovasc Inc. Receives CE Mark for Peripatch-Bv Bovine Pericardial Tissue
Devices Regulatory
 HSMN NewsFeed - 4 Feb 2011
Zolpimist(TM) Oral Spray Launched in United States
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 25 Jan 2011
Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 23 Dec 2010
Mylan's Dey Pharma Partners with Meda to Market EpiPen(R) Auto-Injector in Europe
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 16 Dec 2010
Economic Evaluation of FAME Trial Confirms Using FFR in Treatment of Coronary Artery Disease Is Cost-Effective
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Nov 2010
Mortality Data Presented for Patients Treated with Effient(R) Who Underwent Isolated Coronary Artery Bypass Surgery
Biopharmaceuticals Cardiology Surgery
 HSMN NewsFeed - 15 Nov 2010
Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 9 Nov 2010
Miracor reports successful first-in-man clinical outcome for its PICSO(R) system designed to improve acute coronary syndrome (ACS) revascularization following primary percutaneous coronary intervention (PCI)
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Oct 2010
FDA Approves Pharmaxis' ARIDOL (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
Biopharmaceuticals Diagnostics FDA
 HSMN NewsFeed - 28 Sep 2010
AstraZeneca UK Receives Positive Decision For Seroquel XL(R)[Black Triangle Drug] (Quetiapine Prolonged Release) as an Add-On Treatment of Major Depressive Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Sep 2010
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Sep 2010
Long Term Data Presented at ESC 2010 Further Support the Benefit of The CYPHER(R) Sirolimus Drug-Eluting Stent Compared to The ENDEAVOR(R) Zotarolimus-Eluting Stent in Important High-Risk Subgroups
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Sep 2010
Cardiogenesis Comments on the STAR-Heart Study Presented at European Society of Cardiology (ESC) 2010 Congress
Regenerative Medicine Devices Cardiology
 HSMN NewsFeed - 31 Aug 2010
New 2010 ESC Guidelines for Percutaneous Coronary Interventions Reinforce Importance of FFR in Treatment of Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Aug 2010
Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study
Biopharmaceuticals
 HSMN NewsFeed - 27 Aug 2010
Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 28 Jul 2010
FDA Advisory Committee Recommends US FDA Approval of Brilinta (Ticagrelor) for Acute Coronary Syndromes
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 26 Jul 2010
FDA Approves Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jun 2010
Vasomedical Announces Reorganization of Its Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 9 Jun 2010
NovaDel Pharma Inc. Announces Appointment of Craig Johnson as Senior Vice President, Chief Financial Officer and Secretary
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 25 May 2010
St. Jude Medical Enrolls First Patient in FAME II Clinical Trial to Study Use of Fractional Flow Reserve Technology in Patients With Stable Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Apr 2010
Outcomes of Patients Dismissed from the Hospital with Noncardiac Chest Pain
Cardiology
 HSMN NewsFeed - 9 Apr 2010
Vasomedical Announces FDA 510(k) Clearance on the First Combined ECG Holter and Ambulatory Blood Pressure Monitoring System
Devices Monitoring FDA
 HSMN NewsFeed - 23 Feb 2010
Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic(R)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 11 Feb 2010
OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Feb 2010
Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 29 Jan 2010
Teva UK Limited Launches Lercanidipine Hydrochloride Film-Coated Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 26 Jan 2010
Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Therapy Forum
Biopharmaceuticals Cardiology Regenerative Medicine
 HSMN NewsFeed - 26 Jan 2010
Prometheus Acquires Exclusive Rights to PROLEUKIN(R) (aldesleukin) in the U.S.
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 5 Jan 2010
New Analysis Showed Effient(R) Cost-Effective Compared with Clopidogrel for Patients with Acute Coronary Syndromes Undergoing PCI
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 16 Dec 2009
Importance of FFR in Treatment of Coronary Artery Disease Confirmed by New PCI Guidelines
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Dec 2009
The Medicines Company Receives European Approval for Angiox(R) (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 23 Nov 2009
BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 19 Nov 2009
AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet Agent
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Nov 2009
New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
Diagnostics Cardiology
 HSMN NewsFeed - 10 Nov 2009
PLC Systems Announces Distribution Agreement for RenalGuard(R) in Brazil
Devices Distribution Interventional
 HSMN NewsFeed - 19 Oct 2009
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 5 Oct 2009
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Sep 2009
Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2009
Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
Devices Cardiology
 HSMN NewsFeed - 22 Sep 2009
Final 12 Month Clinical Data from 5,000 Patients in Worldwide e-HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM)
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Sep 2009
PLC Medical Systems Reports Strong Success for RenalGuard(R) at ESC 2009
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Sep 2009
Multiple Presentations at the European Society of Cardiology Congress Document EECP Promotes Coronary Collateral Flow Leading to Sustained Clinical Improvement
Devices Cardiology
 HSMN NewsFeed - 30 Aug 2009
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 3 Aug 2009
Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Jul 2009
Cardiogenesis Corporation Makes Pre-IDE Submission for PHOENIX Combination Delivery System
Devices Cardiology
 HSMN NewsFeed - 29 Jul 2009
Sciele Pharma and Plethora Solutions Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2009
Sciele Pharma, a Shionogi Company, Terminates Agreement to Acquire Victory Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Jun 2009
BARI 2D Study Presented at American Diabetes Association Scientific Sessions Underscores Utility of SPECT Myocardial Perfusion Imaging in Identifying Cardiovascular Risk and Evaluating Treatment Outcomes for Patients with Type 2 Diabetes
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 7 Jun 2009
SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
Devices Interventional Cardiology
 HSMN NewsFeed - 26 May 2009
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 May 2009
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 19 May 2009
Endeavor Drug-Eluting Stent is First to Receive CE Mark for Treating Acute Coronary Syndrome
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 May 2009
AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2009
PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2009
AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 May 2009
Schering-Plough Starts Patient Enrollment in Phase 3 Trial for Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 8 May 2009
New Data Shows AZOR(R) (Amlodipine and Olmesartan Medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 May 2009
Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 4 May 2009
PLC Systems Announces First Distribution Agreement in Spain for RenalGuard(R)
Devices Distribution
 HSMN NewsFeed - 23 Apr 2009
Sciele Pharma and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel Used in Combination with Stimulants to Treat ADHD
Biopharmaceuticals
 HSMN NewsFeed - 8 Apr 2009
World-First Launch of New Heart Drug
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2009
Cardium's InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapy's Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
Devices Neurosurgery
 HSMN NewsFeed - 12 Mar 2009
CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Mar 2009
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2009
BridgePoint Medical Completes First U.S. Clinical Case Using CrossBoss and Stingray Devices in CTO Angioplasty Procedure
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Mar 2009
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
Devices Neurology Cardiology Regulatory
 HSMN NewsFeed - 9 Mar 2009
Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
Devices Urology Oncology
 HSMN NewsFeed - 23 Feb 2009
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 20 Feb 2009
UCB to divest Equasym(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 19 Feb 2009
CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Feb 2009
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 3 Feb 2009
Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 28 Jan 2009
CV Therapeutics Statement on Unsolicited Proposal From Astellas
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 27 Jan 2009
Astellas Proposes to Acquire CV Therapeutics for $16 per Share in Cash
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 27 Jan 2009
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
Biopharmaceuticals
 HSMN NewsFeed - 16 Jan 2009
Hydra Biosciences Raises $22 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Jan 2009
Cleveland Clinic to Present Results from Study Using Ivivi Technologies' tPEMF(tm) on Cardiac Ischemia At American College of Cardiology Annual Meeting
Devices Cardiology
 HSMN NewsFeed - 31 Dec 2008
FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Dec 2008
Boston Scientific Initiates Carotid Stent Clinical Study
Devices Interventional
 HSMN NewsFeed - 16 Dec 2008
Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
Devices Urology
 HSMN NewsFeed - 15 Dec 2008
Cardium's InnerCool Awarded U.S. Supplier Agreement With Novation LLC
Devices Group Purchasing
 HSMN NewsFeed - 2 Dec 2008
Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 26 Nov 2008
PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
Devices Interventional FDA
 HSMN NewsFeed - 11 Nov 2008
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
Devices Urology
 HSMN NewsFeed - 6 Nov 2008
Newly Published Data from Long-Term Study Show Neurostimulation Provides Sustained Leg Pain Relief, Improved Quality of Life and Functional Capacity
Devices Neurosurgery
 HSMN NewsFeed - 6 Nov 2008
FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 20 Oct 2008
Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System
Devices FDA
 HSMN NewsFeed - 12 Oct 2008
Medtronic's Third-Generation Endeavor(R) Resolute Drug-Eluting Stent Maintains Strong Efficacy and Safety Profile at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Sep 2008
Shionogi and Sciele Announce Receipt of United States Antitrust Clearance
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Sep 2008
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 3 Sep 2008
Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Sep 2008
New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Sep 2008
New Data Shows Anticlotting Medicine, AGGRASTAT(R), Lowers Incidence of Heart Attack, in Patients Who Respond Poorly to Aspirin or Clopidogrel, after Elective Coronary Angioplasty
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Aug 2008
Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Aug 2008
CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 21 Jul 2008
Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Jul 2008
Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
Devices Regulatory
 HSMN NewsFeed - 14 Jul 2008
FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 2 Jul 2008
Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing
Devices Acquisitions
 HSMN NewsFeed - 1 Jul 2008
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals To Develop and Market ADX415 for the Treatment of Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 24 Jun 2008
FDA Approves PrandiMet(TM), a Replaglinide and Metformin Fixed-Dose Combination Tablet for Treatment of Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology
 HSMN NewsFeed - 24 Jun 2008
Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging (MPI)
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 18 Jun 2008
Cardiogenesis Announces Preliminary Results Combining TMR + Platelet Rich Plasma (PRP)
Devices Cardiology Regenerative Medicine
 HSMN NewsFeed - 4 Jun 2008
LifeWatch Corp. Parent Company, Card Guard AG Receives Full FDA Clearance for Next-Generation LifeStar ACT III Platinum System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 1 Jun 2008
New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2008
PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM)
Devices Interventional Cardiology
 HSMN NewsFeed - 28 May 2008
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 May 2008
NovaDel Announces European License Agreement for Ondansetron Oral Spray
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 May 2008
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 May 2008
PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2008
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Apr 2008
Cardium Reports on Science Channel Series Featuring InnerCool's Endovascular Cooling During Brain Surgery at Stanford University
Devices Neurosurgery
 HSMN NewsFeed - 29 Apr 2008
Genentech and Biogen Idec Announce Top-Line Results from Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 24 Apr 2008
European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 15 Apr 2008
CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2008
Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
Devices Cardiology
 HSMN NewsFeed - 15 Apr 2008
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
Biopharmaceuticals Generics Litigation Distribution
 HSMN NewsFeed - 7 Apr 2008
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
Biopharmaceuticals
 HSMN NewsFeed - 1 Apr 2008
CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Apr 2008
Lipitor Provided an Unexpectedly Potent Heart Benefit in Patients with Chronic Stable Angina, According to New Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2008
Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2008
Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 30 Mar 2008
Filter Fails to Improve PCI Outcomes in Acute Coronary Syndromes
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Angiomax Demonstrated Improved Outcomes in Acute Heart Attack Patients Undergoing Primary Angioplasty Independent of Individual Risk Factors
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 28 Mar 2008
PLC Systems Announces First International Distribution Agreement for RenalGuard(TM)
Devices Radiology Interventional Distribution
 HSMN NewsFeed - 25 Mar 2008
Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 Mar 2008
PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
Devices FDA
 HSMN NewsFeed - 19 Mar 2008
Cardium's InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
Devices Distribution
 HSMN NewsFeed - 13 Mar 2008
Sciele Pharma Acquires Twinject(R) Epinephrine Auto-Injector from Verus Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 5 Mar 2008
Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Mar 2008
New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 27 Feb 2008
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Feb 2008
Sciele Expands Alliance with Sanofi-Aventis to Market Allegra(R) (Fexofenadine HCL) Orally Disintegrating Tablets (ODT) and Allegra(R) Oral Suspension (OS) in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2008
Sciele Pharma and LifeCycle Pharma Announce U.S. Market Launch of Fenoglide(TM)
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2008
Altor BioScience In-Licenses Tissue Factor Antagonists from Genentech
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Feb 2008
CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVT's Innovative Stent Coating Technology
Devices Licensing
 HSMN NewsFeed - 30 Jan 2008
Medical Ventures to Acquire Two Vascular Device Developers
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 30 Jan 2008
Iroko Pharmaceuticals Acquires Rights to Cardiovascular Product from Merck & Co., Inc.
Biopharmaceuticals Cardiology Acquisitions
 HSMN NewsFeed - 29 Jan 2008
The Medicines Company's Angiox(R) Receives European Authorization for Expanded Use in Patients with Acute Coronary Syndromes (ACS)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 28 Jan 2008
Clexane(R)/Lovenox(R) Approved in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Jan 2008
Medicare Increases Rates for Vasomedical EECP Therapy for 2008
Devices Cardiology Reimbursement
 HSMN NewsFeed - 23 Jan 2008
NovaDel's New Drug Application for ZolpiMist(TM) Oral Spray to Treat Insomnia Accepted for Filing by the U.S. Food and Drug Administration
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 Jan 2008
Sciele Pharma Announces FDA Approval of New Sular(R) Formulation
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 21 Dec 2007
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 19 Dec 2007
PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
Biopharmaceuticals Radiology Interventional
 HSMN NewsFeed - 18 Dec 2007
FDA Approves New Mechanism of Action Labeling for Ranexa(R)
Biopharmaceuticals. Cardiology FDA
 HSMN NewsFeed - 18 Dec 2007
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 17 Dec 2007
GlaxoSmithKline Announces Data on TYKERB(R) (Lapatinib) Plus Capecitabine for the Treatment of HER2 Positive Breast Cancer Brain Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Dec 2007
FDA Advisory Panel Recommends Against Approval of Merck's NDA for Non-prescription MEVACOR(R) (lovastatin) 20 mg
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 13 Dec 2007
PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Dec 2007
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 11 Dec 2007
GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 7 Dec 2007
FDA Reviewing Potential Anti-Arrhythmic Claims for Ranexa(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Dec 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 5 Dec 2007
Edward J. Schutter Appointed to President and Chief Operating Officer of Sciele Pharma, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Nov 2007
Tasigna(R) gains European approval for patients with a life-threatening form of leukemia who are resistant or intolerant to existing therapies
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Nov 2007
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
Biopharmaceuticals
 HSMN NewsFeed - 26 Nov 2007
Corgenix Releases Clinical Trial Data on AtherOx(TM)
Diagnostics
 HSMN NewsFeed - 19 Nov 2007
Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 19 Nov 2007
Sciele Signs Exclusive Agreement with Novo Nordisk to Market Prandin(R) and PrandiMet(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 14 Nov 2007
Cardium and InnerCool Complete $5 Million Commercial Financing to Support Launch of New Product Lines
Devices
 HSMN NewsFeed - 14 Nov 2007
GSK Revises US Labeling for Avandia(R)
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 13 Nov 2007
Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
Devices Cardiology FDA
 HSMN NewsFeed - 8 Nov 2007
Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Nov 2007
New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Nov 2007
Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Nov 2007
COURAGE Sub-study: PCI Outperforms Drugs-Only
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Nov 2007
CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 6 Nov 2007
Acusphere Announces Data Demonstrating Imagify(TM) Perfusion Stress Echo is Well-tolerated and as Effective as Nuclear Perfusion Imaging for Evaluating Chest Pain Patients at Risk for Heart Attack
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Nov 2007
Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 4 Nov 2007
In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 30 Oct 2007
Sciele Pharma and Addrenex Announce Initiation of Pivotal Phase III Trials for Clonicel for ADHD
Biopharmaceuticals
 HSMN NewsFeed - 29 Oct 2007
Tasigna(R) receives US approval providing new hope to chronic myeloid leukemia patients with resistance or intolerance to existing therapies
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Oct 2007
InnerCool Licenses New Therapeutic for Potential Use in Stroke Patients
Devices Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 22 Oct 2007
PLC Medical Systems to Introduce RenalGuard(TM) at TCT 2007
Devices Interventional
 HSMN NewsFeed - 22 Oct 2007
Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Oct 2007
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 15 Oct 2007
Celera and Collaborators Identify a Five-Gene Genetic Risk Score(TM) That Predicts Risk of Coronary Heart Disease
Diagnostics Cardiology
 HSMN NewsFeed - 10 Oct 2007
Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 4 Oct 2007
Salix Pharmaceuticals Licenses OSMOPREP(TM) To Mayoly-Spindler in France
Biopharmaceuticals Licensing Gastroenterology
 HSMN NewsFeed - 1 Oct 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
Biopharmaceuticals
 HSMN NewsFeed - 27 Sep 2007
CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 27 Sep 2007
AZOR(TM) Receives FDA Approval for Treatment of High Blood Pressure
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Sep 2007
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 24 Sep 2007
FDA Accepts sNDA for Expanded Use of Angiomax(R) (bivalirudin)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 21 Sep 2007
The CYPHER(R) Sirolimus-Eluting Coronary Stent Outperforms the Taxus Stent in Small Coronary Vessels According to New Clinical Data Analysis Published in the Journal of the American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Sep 2007
Actavis Launches Amlodipine Tablets in the U.S.
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Sep 2007
Angiox(R) (Bivalirudin) Alone Reduced Early Bleeding and Resulted in Similar One-Year Mortality Compared to Heparins Plus GP IIb/IIIa Combination Therapy in ACS Patients Undergoing Angioplasty
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Sep 2007
New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 Aug 2007
Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Aug 2007
CV Therapeutics Launches 1000 mg Ranexa(R) Tablet
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Aug 2007
Actavis Receives Approval for Generic Inderal LA Capsules in the U.S.
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 13 Aug 2007
Sciele Pharma and Lifecycle Pharma Announce FDA Approval of New Formulation of Fenofibrate in 120 Mg. and 40 Mg. Dosage Strengths
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Aug 2007
NovaDel Announces Sublicense Agreement for Zensana(TM)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 25 Jul 2007
Jan H. Egberts, M.D. Resigns as President and CEO of NovaDel Pharma
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2007
Schering-Plough Announces Licensing of Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 18 Jul 2007
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 16 Jul 2007
CV Therapeutics Names Lewis Stuart Senior Vice President, Commercial Operations
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 16 Jul 2007
Sciele Pharma Acquires a Novel, Patented Treatment for Head Lice from Summers Laboratories, Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 Jul 2007
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals to Market CLONICEL(R)
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2007
Ranbaxy Receives Final Approval To Manufacture and Market Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Jul 2007
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 29 Jun 2007
Teva Announces Approval of Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Jun 2007
Ivivi Technologies Announces Completion of Patient Enrollment for its Cardiac Clinical Trial at The Cleveland Clinic Florida
Devices Cardiology
 HSMN NewsFeed - 21 Jun 2007
Vasomedical Announces a New Strategic Alliance with Living Data Technology Corp.
Devices Cardiology
 HSMN NewsFeed - 21 Jun 2007
Exforge(R) Receives Final US Approval as New and Powerful Treatment Option for Patients With High Blood Pressure
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jun 2007
Paul J. McCormick Elected Chairman of Cardiogenesis Corporation
Devices Cardiology Personnel
 HSMN NewsFeed - 20 Jun 2007
Ranbaxy Receives Tentative Approval to Manufacture and Market Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jun 2007
Sciele Pharma Completes Acquisition of Alliant Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Jun 2007
Salix Pharmaceuticals Announces Imminent Launch of Visiclear(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2007
Health Canada's approval of an expanded indication for PLAVIX(R) (clopidogrel bisulfate) now offers protection from all types of heart attacks
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 4 Jun 2007
GSK's Pazopanib Shows Positive Results in Patients With Advanced Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
Glaxosmithkline Reports Positive New Data on Tykerb(R)(Lapatinib) at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2007
Peter M. Strumph Named CEO of Nile Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2007
Sciele Enters Into Exclusive License Agreement with Plethora Solutions Limited to Market PSD502 for the Treatment of Premature Ejaculation
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 May 2007
CV Therapeutics Significantly Reduces Operating Expenses
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2007
Five-Year Fractional Flow Reserve Data Confirms Benefit of Deferral of Stenting
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2007
PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2007
Devices Interventional
 HSMN NewsFeed - 18 May 2007
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 May 2007
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 14 May 2007
CV Therapeutics Submits New Drug Application For Regadenoson
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 10 May 2007
Cardiogenesis Announces Submission of PMA Supplement for Minimally Invasive Robotic Delivery System
Devices Cardiology
 HSMN NewsFeed - 2 May 2007
FDA Approves FRAGMIN(R) as First Low-Molecular-Weight Heparin for Extended Treatment to Reduce the Recurrence of Blood Clots in Patients with Cancer
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Apr 2007
Journal of the American Medical Association Publishes MERLIN TIMI-36 Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 24 Apr 2007
Sciele Pharma to Acquire Alliant Pharmaceuticals, a Pediatric Specialty Pharmaceutical Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Apr 2007
Cardiogenesis Announces the Addition of Paul J. McCormick to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 18 Apr 2007
Schering-Plough Announces Initiation of Two Phase III Clinical Trials for Novel Selective Antiplatelet Therapy (TRA-SCH 530348)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Apr 2007
Sciele Begins to Enroll Patients in a Pivotal Phase III Clinical Trial for the Combination of Pravastatin and Fenofibrate
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Apr 2007
COURAGE, SPIRIT Data May Support Role of Advanced Imaging and Diagnosis With IVUS and FFR
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2007
Novartis Suspends US Marketing and Sales of Zelnorm(R) in Response to Request from FDA
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 27 Mar 2007
Huntington Hospital Cardiologist Available to Comment on Courage Study
Devices Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 27 Mar 2007
SCAI Leaders Say Courage Results Unlikely to Change Use of PCI
Devices Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2007
ACUITY One-Year Findings Meet All Primary Endpoints in Favor of Angiomax(R) (Bivalirudin) Alone Treatment Group
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Mar 2007
First Study to Show Positive Benefit on Atherosclerosis for People With Early Signs of Diseased Arteries
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Mar 2007
First Patient Enrolled in RAPID MI-ICE Study Employing InnerCool's Endovascular Temperature Modulation Therapy for Heart Attack
Devices Cardiology
 HSMN NewsFeed - 21 Mar 2007
PLC Systems Announces Change in Exclusive Distributor of TMR Products From Edwards Lifesciences to Novadaq Technologies Inc.
Devices Cardiology Distribution
 HSMN NewsFeed - 20 Mar 2007
MGI PHARMA Announces Positive Results from a Pivotal Phase 3 Study of Aquavan(R) Injection in Patients Undergoing Bronchoscopy
Biopharmaceuticals
 HSMN NewsFeed - 16 Mar 2007
First Patients Treated In RenalGuard(TM) Investigational Study By PLC Medical Systems
Devices Interventional
 HSMN NewsFeed - 16 Mar 2007
Endo and Vernalis plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Mar 2007
JACC Publishes Long-Term Safety and Tolerability Data from Ranolazine Open Label Experience (ROLE) Program
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Mar 2007
CV Therapeutics Announces Topline MERLIN TIMI-36 Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Mar 2007
Lipitor Significantly Reduced the Risk of Serious Cardiovascular Events Compared With Simvastatin in an 80,000-Patient Analysis of a Real-World Managed Care Database
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Feb 2007
St. Jude Medical Announces Spinal Cord Stimulation Pilot Study for Chronic Angina
Devices Neurology Cardiology
 HSMN NewsFeed - 7 Feb 2007
FDA Grants Priority Review to Lovenox(R) (Enoxaparin Sodium Injection) Supplemental New Drug Application (sNDA) for Acute Heart Attack
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Feb 2007
Dr. David D. Waters Joins Anthera Pharmaceuticals as Cardiovascular Research Fellow
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2007
Cardium and InnerCool Announce New External and Internal Patient Temperature Modulation Systems
Devices
 HSMN NewsFeed - 2 Feb 2007
GlaxoSmithKline Receives Approvable Letter for New Indications for ARIXTRA(R) (Fondaparinux Sodium) Injection
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 29 Jan 2007
Par Pharmaceutical Receives Approval of Generic Inderal-LA(R)
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 16 Jan 2007
Enrollment Completed in Pivotal Phase III Study Comparing Prasugrel to Clopidogrel in Patients With Acute Coronary Syndrome
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Jan 2007
Ranbaxy Granted Final U.S. FDA Approval to Manufacture and Market Atenolol Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 20 Dec 2006
CV Therapeutics Files Application for European Marketing Approval of Ranolazine for Treatment of Chronic Angina
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 20 Dec 2006
Sciele Pharma Signs Exclusive Zovirax(R) Promotional Agreement with Biovail
Biopharmaceuticals
 HSMN NewsFeed - 13 Dec 2006
New England Journal of Medicine Publishes Data from Pivotal Study of Avastin Plus Chemotherapy in Most Common Type of Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Dec 2006
OSMOPREP(TM) Tablets Granted MHRA Marketing Approval
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Dec 2006
Actelion Ltd. Announces Commencement of Cash Tender Offer for CoTherix, Inc. and HSR Clearance to Acquire CoTherix, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Dec 2006
Cardium's Generx Advances to Phase 3 Following Meeting With FDA
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Dec 2006
Vasomedical EECP(R) Therapy Provides Greater Benefit in Older Heart Failure Patients
Devices Cardiology
 HSMN NewsFeed - 5 Dec 2006
PLC Systems Announces Discontinuation of Optiwave Program by Edwards Lifesciences
Devices Cardiology
 HSMN NewsFeed - 4 Dec 2006
Regadenoson Meets Primary Endpoint in Second Phase 3 Clinical Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 30 Nov 2006
Cardium Announces Formation of Scientific Advisory Board
Devices Personnel
 HSMN NewsFeed - 29 Nov 2006
RejuvaCell's Breakthrough Stem Cell Therapy Demonstrates Potential to Revolutionize Treatment for Type-2 Diabetes
Regenerative Medicine Endocrinology
 HSMN NewsFeed - 22 Nov 2006
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Nov 2006
Par Pharmaceutical Begins Shipment of Generic TOPROL-XL(R)
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 20 Nov 2006
Richard Lanigan Appointed President
Devices Personnel
 HSMN NewsFeed - 20 Nov 2006
Actelion Announces Definitive Agreement to Acquire U.S.-Based CoTherix, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Nov 2006
Studies Presented at AHA Confirm Role of Inflammatory Marker Lp-PLA2 in Assessing Cardiovascular Risk and in Secondary Prevention
Diagnostics Cardiology
 HSMN NewsFeed - 13 Nov 2006
Treatment of Diabetic Foot Ulcers to Be Addressed at Upcoming American Heart Association Meeting
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 3 Nov 2006
Corautus Genetics Announces Redirection of Focus and Transition Of Officers
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 3 Nov 2006
NovaDel Pharma Receives FDA Approval of NitroMist(TM)
Biopharmaceuticals Drug Delivery FDA Cardiology
 HSMN NewsFeed - 3 Nov 2006
Newly-Published Data Showed LEVITRA(R) Treated Erectile Dysfunction Effectively at First Dose In Men With Certain Associated Cardiovascular Conditions
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2006
MediciNova Announces the Acquisition of Two Novel Antithrombotic Agents from Meiji Seika Kaisha, Ltd.
Biopharmaceuticals Cardiology Acquisitions
 HSMN NewsFeed - 26 Oct 2006
CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2006
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 24 Oct 2006
Cardium Reports on Positive Effects of Hypothermia Following Heart Attack and Announces Clinical Study to Be Co-Sponsored by Swedish Cardiology Center
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
PLC Systems Receives FDA Permission to Begin RenalGuard(TM) Investigational Study
Devices FDA
 HSMN NewsFeed - 23 Oct 2006
Boston Scientific Reports Positive Results for its Carotid Artery Stenting Trial
Devices Interventional
 HSMN NewsFeed - 23 Oct 2006
New Study Shows Prasugrel Achieves Faster Onset and Higher Levels of Platelet Inhibition than Clopidogrel at Approved or Higher Doses
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Oct 2006
Caritas St. Elizabeth's Medical Center's Study Finds Injecting Patient's Own Stem Cells into the Heart to Treat Severe Coronary Artery Disease is Well Tolerated
Biopharmaceuticals Regenerative Medicine Cardiology
 HSMN NewsFeed - 23 Oct 2006
Salix Pharmaceuticals Reports American College of Gastroenterology Update
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 19 Oct 2006
CryoCath enrolls first patient in U.S. AF trial
Devices Cardiology
 HSMN NewsFeed - 18 Oct 2006
AVI BioPharma Initiates NEUGENE Antisense Clinical Program in Coronary Artery Bypass Grafting
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 Oct 2006
Vasomedical Introduces Wireless Data Management System
Devices
 HSMN NewsFeed - 11 Oct 2006
Cardiogenesis Announces Opening of New Facility
Devices
 HSMN NewsFeed - 11 Oct 2006
CV Therapeutics Ending Co-Promotion of ACEON(R) (perindopril erbumine) Tablets
Biopharmaceuticals
 HSMN NewsFeed - 10 Oct 2006
DOV Pharmaceutical, Inc. Announces New Strategic Direction, Bicifadine Clinical Studies Results and Program Updates
Biopharmaceuticals
 HSMN NewsFeed - 10 Oct 2006
Corautus Genetics Announces Final Efficacy Results of GENASIS Phase IIb Clinical Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Oct 2006
CV Therapeutics Receives Notices of Allowance From U.S. Patent and Trademark Office and European Patent Office for Drug-Eluting Stent Technology
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Oct 2006
Arixtra(R) Receives Priority Review by the FDA in Acute Coronary Syndromes (ACS)
Biopharmaceuticals Cardiology Generics
 HSMN NewsFeed - 2 Oct 2006
FDA Grants Priority Review for ARIXTRA(R) (fondaparinux sodium) in the Treatment of Acute Coronary Syndromes
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 28 Sep 2006
Sciele Pharma Introduces OSTIVA(TM), a New Women's Health Product
Biopharmaceuticals
 HSMN NewsFeed - 26 Sep 2006
CV Therapeutics Completes MERLIN TIMI-36 Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Sep 2006
Dr. Michael Morgan Reports on Benefits of InnerCool's Celsius Control System in Inducing Hypothermia During Aneurysm Surgery
Devices Neurosurgery
 HSMN NewsFeed - 19 Sep 2006
Benefits of Vasomedical's EECP Therapy in Heart Failure Presented at the 10th Annual HFSA Scientific Meeting
Devices Cardiology
 HSMN NewsFeed - 15 Sep 2006
Avandia(R) (rosiglitazone maleate) Reduced Risk of Progression From Pre-Diabetes To Type 2 Diabetes by 62 Percent in Largest Completed Diabetes Prevention Trial
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 12 Sep 2006
KV Pharmaceutical Company Receives ANDA Approval From U.S. FDA for Six Strengths of Diltiazem HCl ER Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Sep 2006
Heartscape Technologies Appoints Arthur Hiller, former Millennium Head of Cardiovascular Business, as CEO and Director
Devices Cardiology
 HSMN NewsFeed - 7 Sep 2006
European commission expands indication for PLAVIX® (clopidogrel bisulfate) offering new option for patients with most severe type of heart attack
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 6 Sep 2006
Amlodipine Based Regimen to Lower Blood Pressure, Reduces the Risk of New-Onset Diabetes in Hypertensive Patients by More Than a Third
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Sep 2006
Lipitor More Effective Than Simvastatin in Cutting Risk of Additional Heart Attacks in Patients Who Had a Recent Heart Attack, New Data Suggests
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Sep 2006
New Clinical Data Show Enoxaparin Significantly Reduced the Risk of Repeat Heart Attack and Stroke in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Biopharmacetuicals Cardiology
 HSMN NewsFeed - 5 Sep 2006
CryoCath receives FDA approval to start AF trial
Devices Cardiology FDA
 HSMN NewsFeed - 4 Sep 2006
New Clinical Data Show Enoxaparin Significantly Reduces the Risk of Repeat Heart Attacks and Stroke in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 29 Aug 2006
Positive PEECH Trial Results and Related Article Highlighting Mechanism of Action Published in the Journal of the American College of Cardiology
Devices Cardiology
 HSMN NewsFeed - 17 Aug 2006
FDA Approves New Indication for PLAVIX(R) (clopidogrel bisulfate) Offering New Option for Patients With Most Severe Type of Heart Attack
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 14 Aug 2006
Cardium Acquires Excellarate Product Candidate for Chronic Diabetic Ulcers and Related Technology and Assets From Tissue Repair Company
Biopharmaceuticals Wound Care Acquisitions
 HSMN NewsFeed - 9 Aug 2006
Medicure Acquires U.S. Rights to Aggrastat'R' from MGI PHARMA, INC.
Biopharmaceuticals Cardiology Acquisitions
 HSMN NewsFeed - 24 Jul 2006
Biovail and Athpharma Terminate Joint Development Agreement
Biopharmaceuticals
 HSMN NewsFeed - 20 Jul 2006
CryoCath Announces Management Change
Devices Cardiology Personnel
 HSMN NewsFeed - 19 Jul 2006
Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of Menstrual Migraine
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Jul 2006
Corautus Genetics Announces Partial Lifting of FDA Clinical Hold and Update on GENASIS Database Lock
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 12 Jul 2006
Kos Submits Supplemental New Drug Application To FDA For New Niaspan(R) CF Range of Products
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 7 Jul 2006
CV Therapeutics Announces MERLIN TIMI-36 Study to Continue as Planned Based on Final Scheduled DSMB Meeting
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Jun 2006
CoTherix Licenses Exclusive Rights to Develop and Commercialize Oral and Inhaled Formulations of Fasudil for the Treatment of PAH and Stable Angina in North America and Europe From Asahi Kasei Pharma
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 Jun 2006
CV Therapeutics Acquires Rights to Ranolazine in Asia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Jun 2006
New Data Reveals That Enoxaparin Results in Significant Cost Savings Compared to Unfractionated Heparin (UFH) in Treatment of in-Hospital Patients at Risk for Venous Thromboembolism (VTE)
Biopharmaceuticals
 HSMN NewsFeed - 19 Jun 2006
Cryocath reports positive AF data at major European conference
Devices Cardiology
 HSMN NewsFeed - 19 Jun 2006
JACC Publishes ERICA Trial Results Showing Ranexa(R) Reduces Angina Frequency and Nitroglycerin Consumption
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 Jun 2006
First Horizon Pharmaceutical Corporation Stockholders Approve Name Change to Sciele Pharma, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 14 Jun 2006
First Horizon Receives FDA Orphan Drug Designation for Its Glycopyrrolate to Treat Chronic Drooling in Pediatric Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jun 2006
PTC Therapeutics and CV Therapeutics Announce Collaboration and License Arrangement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Jun 2006
FDA Approves New Lotrel(R) 5/40 mg and 10/40 mg Dosage Strengths
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jun 2006
Kos Announces Completion of Patient Randomization for Jerini's Phase III Clinical Trials of Icatibant for the Subcutaneous Treatment of Hereditary Angioedema
Biopharmaceuticals
 HSMN NewsFeed - 7 Jun 2006
CV Therapeutics Completes Enrollment of Second Regadenoson Phase 3 Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Jun 2006
Cardium Reports Meta-Analysis of Angiogenic Gene Therapy Studies Shows Positive Effects in Men and Women With Heart Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Jun 2006
Dr. Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2006
Nuvelo Announces Completion of Phase 2 Heparin Replacement Trial Evaluating rNAPc2 in Acute Coronary Syndromes
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 May 2006
Corautus Genetics Announces Filing of Response to FDA Clinical Hold
Biopharmaceuticals Devices Drug Delivery Cardiology FDA
 HSMN NewsFeed - 26 May 2006
FDA Accepts Submission for NitroMist as Complete Response
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 May 2006
Cardiogenesis Names William R. Abbott Senior Vice President, Chief Financial Officer, Secretary and Treasurer
Devices Cardiology Personnel
 HSMN NewsFeed - 24 May 2006
UCB Completes Mutual Recognition Procedure for Equasym(TM) XL
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 May 2006
Endeavor Registry Data Confirms High Deliverability Success and Broad, Everyday Use by Physicians
Devices Interventional Cardiology
 HSMN NewsFeed - 17 May 2006
PLC Systems' CO2 TMR Heart Laser Technology Receives Marketing Approval in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 16 May 2006
X-Cell Medical Completes Enrollment for Clinical Trial of ETHOS II Estradiol Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 11 May 2006
Federal Appeals Court Rules in Cardium's Favor Over Boston Scientific and Arch Development on Patents for the Treatment of Heart Disease
Devices Cardiology Litigation
 HSMN NewsFeed - 9 May 2006
Angina Patients Cost Managed Care Over Twice as Much as Coronary Artery Disease Patients Without Angina
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 8 May 2006
Kos and SkyePharma Sign Exclusive License Agreement for the Marketing and Distribution of Flutiform(TM) in the United States
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 8 May 2006
Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual Migraine
Biopharmaceuticals
 HSMN NewsFeed - 8 May 2006
SkyePharma and Kos Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in the United States
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 3 May 2006
Vasomedical Sells Its 1,000th EECP Therapy System
Devices Cardiology
 HSMN NewsFeed - 27 Apr 2006
Cardiogenesis Announces Update on Minimally Invasive Treatments for Angina
Devices Cardiology
 HSMN NewsFeed - 27 Apr 2006
Brain Protectant Drug Successfully Completes Safety Trial
Biopharmaceuticals Cardiology Surgery Neurology
 HSMN NewsFeed - 24 Apr 2006
CryoCath Reports Positive AF Data at European Cardiac Conference
Devices Cardiology
 HSMN NewsFeed - 19 Apr 2006
Salix Announces Completion of OsmoPrep(TM) versus Liquid Bowel Cleanser Comparison Study
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 19 Apr 2006
Corautus Genetics Inc. Names Todd Stallings as Vice President - Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2006
Centers for Medicare and Medicaid Services (CMS) Advises Plans Niaspan(R) is Now a Part D Eligible Drug
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 11 Apr 2006
Inflammatory-Enzyme Shown to Predict Risk of Cardiovascular Events After Acute Coronary Syndromes
Biopharmaceuticals Diagnostics Cardiology
 HSMN NewsFeed - 10 Apr 2006
Corautus Announces Termination of Patient Enrollment in GENASIS Severe Angina Clinical Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Apr 2006
ARIXTRA(R) Significantly Reduced Major Bleeding Compared to LOVENOX(R) in a Study of Patients With Acute Coronary Syndromes
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Apr 2006
New Research Shows That Celebrex Helps Stop Growth of Pre-Cancerous Colorectal Polyps in Patients at High Risk for Colon Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Mar 2006
Cardium Announces Patent Wins Over Boston Scientific and Arch Development Corporation, Distinguishes Competitive Approach for the Treatment of Coronary Heart Disease
Devices Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Mar 2006
Study Shows LEVITRA(R) Treats Erectile Dysfunction Effectively in Men Taking Medications to Lower High Blood Pressure
Biopharmaceuticals
 HSMN NewsFeed - 20 Mar 2006
Corautus Genetics Reports Fourth Quarter and 2005 Financial Results and Provides Update on Temporary Suspension of GENASIS Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Mar 2006
OsmoPrep(TM) Tablets Granted FDA Marketing Approval
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Mar 2006
PLC Systems and Edwards Lifesciences Modify Business Agreement for the Optiwave 980 Cardiac Laser Ablation System
Devices Cardiology
 HSMN NewsFeed - 14 Mar 2006
ARIXTRA(R) (Fondaparinux Sodium) Reduced Risk of Death or Recurrent Heart Attack in Patients With Acute Coronary Syndromes (ST Elevation Myocardial Infarction)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Mar 2006
African American Heart Failure Trial Shows Women and Men Both Benefit from BiDil(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Mar 2006
Cardium Announces Addition of Kelly D. Scott as Vice President of New Medical Technology Business
Devices Personnel
 HSMN NewsFeed - 13 Mar 2006
Researchers Identify Gene Variations That May Determine Which Heart Failure Patients Are Likely to Benefit from Treatment With BiDil(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Mar 2006
New Data Presented at American College of Cardiology Meeting Compares the AstraZeneca Investigational Drug AZD6140 to Clopidogrel for Inhibition of Platelet Aggregation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 Mar 2006
Vasogen Announces Results from Phase III SIMPADICO Trial in Peripheral Arterial Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 Mar 2006
New Study Furthers Understanding of the Role of Dual Antiplatelet Therapy in the Prevention Of Atherothrombotic Events, Including Heart Attack, Stroke or Cardiovascular Death in Broad Population
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 10 Mar 2006
CV Therapeutics Begins Shipments of Ranexa to Wholesalers
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 9 Mar 2006
Cardium Acquires InnerCool Therapies, a Leading Provider of FDA-Cleared Therapeutic Hypothermia Systems
Devices Mergers & Acquisitions
 HSMN NewsFeed - 8 Mar 2006
X-Cell Medical Initiates Enrollment for ETHOS II Clinical Trial of Estradiol Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Mar 2006
Telzuit Medical Technologies, Inc. Signs Co-Marketing and Sales Agreement with Cardiomedics, Inc.
Devices Cardiology Monitoring
 HSMN NewsFeed - 7 Mar 2006
Baxter Commences First-Of-Its-Kind, Phase II Adult Stem Cell Trial in U.S. in Patients With Severe Coronary Artery Disease
Regenerative Medicine Cardiology
 HSMN NewsFeed - 7 Mar 2006
Cardiogenesis Announces Publication on Holmium:YAG TMR System in Prominent Scientific Journal
Devices Cardiology
 HSMN NewsFeed - 23 Feb 2006
Corautus Genetics Announces Update on GENASIS Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Feb 2006
Kos Reports Summary Results of Key Phase IV Research and Development Studies
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2006
BioSante Pharmaceuticals Comments on New Data from Women's Health Initiative Study Showing No Increased Coronary Heart Risk with Estrogen-Alone Therapy
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Feb 2006
Senetek Licenses Invicorp(R) Erectile Dysfunction Treatment to Plethora Solutions for North America
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Feb 2006
New Data from Women's Health Initiative Study Show No Increased Risk of Coronary Heart Disease with Conjugated Estrogens Alone In Any Age Group Studied
Biopharmaceuticals
 HSMN NewsFeed - 9 Feb 2006
Cardiogenesis Announces Successful Clinical Application of PHOENIX TMR Plus Stem Cell Delivery System
Devices Cardiology Regenerative Medicine
 HSMN NewsFeed - 7 Feb 2006
Cardiogenesis Names Larry J. Czapla Senior Vice President, Worldwide Sales and Business Development
Devices Cardiology Personnel
 HSMN NewsFeed - 31 Jan 2006
Study Results Indicate the CYPHER(R) Sirolimus-Eluting Coronary Stent May Reduce Re-Blockage and Chances of Major Side Effects in Patients with Complex Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Jan 2006
FDA Approves Ranexa
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 26 Jan 2006
Corautus Genetics' Phase IIb Clinical Trial for Severe Angina Treatment Receives Go-Ahead from Data Safety Monitoring Committee Based on Final Scheduled Interim Safety Data Review
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Jan 2006
CardioTech Begins Process to Obtain an IDE in the U.S. for CardioPass Coronary Graft
Devices Surgery Cardiology FDA
 HSMN NewsFeed - 23 Jan 2006
Cardium Therapeutics Announces Appointment of Chief Medical Officer to Lead Generx(TM) Development Program
Biopharmaceuticals Interventional Cardiology Personnel
 HSMN NewsFeed - 20 Jan 2006
CryoCath announces management changes
Devices Personnel
 HSMN NewsFeed - 19 Jan 2006
Cardiogenesis Announces FDA Approval for PMC Clinical Trial
Devices Cardiology FDA
 HSMN NewsFeed - 18 Jan 2006
FDA Grants Priority Review to PLAVIX(R) (Clopidogrel Bisulfate) Supplemental New Drug Application (sNDA) for Additional Type of Heart Attack
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 16 Jan 2006
CryoCath Reports Positive Data at Atrial Fibrillation Conference
Devices Cardiology
 HSMN NewsFeed - 10 Jan 2006
Dade Behring Grants Sublicense to Abbott for the Use of Placental Growth Factor (PlGF) for the Diagnosis of Cardiovascular Diseases
Diagnostics Licensing Cardiology
 HSMN NewsFeed - 3 Jan 2006
FDA Clears NT-proBNP Test for New Risk Stratification Use
Diagnostics FDA Cardiology
Return to NewsFeed  

 Additional items found! 364

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 364 additional stories matching:
angina
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.